Star Scientific, Inc. 

(Public, NASDAQ:STSI)   Watch this stock   
Find more results for stsi
Dec 4, 2009
Shareholders Meeting - 9:30AM EST - Add to calendar
Nov 9, 2009
Q3 2009 Earnings Release
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin -2112.93% -4066.07%
Operating margin -2125.00% -4630.15%
EBITD margin - -4496.67%
Return on average assets -91.88% -135.46%
Return on average equity -261.27% -
Employees 42 -

Address

16 South Market Street
Petersburg, VA 23803
United States - Map
+1-804-8610681 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance

Star Scientific, Inc. discussions

  View all discussions »

Description

Star Scientific, Inc. (Star Scientific) is a tobacco company that focuses on reducing toxins in tobacco leaf and tobacco smoke. The Company is primarily engaged in the development, implementation and licensing of its technology for the curing of tobacco to prevent the formation of carcinogenic toxins present in tobacco and tobacco smoke, primarily the tobacco-specific nitrosamines (TSNAs); the manufacture, sales, marketing and development of very low-TSNA dissolvable smokeless tobacco products, including ARIVA compressed powdered tobacco cigalett pieces, and STONEWALL Hard Snuff, and the licensing of trademarks for certain of its cigarette brands. Star Scientific is also engaged in the development of pharmaceutical products that have a botanical, tobacco-based component, that are designed to treat tobacco dependence and a range of neurological conditions, including Alzheimer’s disease, Parkinson’s disease, schizophrenia and depression and related products such as, neutraceuticals.

Officers and directors

Paul L. Perito
Chairman of the Board, President, Chief Operating Officer
Age: 72
Bio & Compensation - Reuters
Jonnie R. Williams
Chief Executive Officer, Director
Age: 53
Bio & Compensation - Reuters
Park A. Dodd III
Chief Financial Officer, Treasurer, Assistant Secretary
Age: 56
Bio & Compensation - Reuters
Paul H. Lamb III
President of Star Tobacco, Inc.
Age: 75
Bio & Compensation - Reuters
David M. Dean
Vice President - Sales and Marketing
Age: 49
Bio & Compensation - Reuters
Robert E. Pokusa
General Counsel
Age: 58
Bio & Compensation - Reuters
Curtis Wright M.D.
Senior Vice President - Medical, Clinical Director of Star Pharma
Age: 59
Bio & Compensation - Reuters
Leo S. Tonkin
Director
Age: 71
Bio & Compensation - Reuters
Neil L. Chayet
Director
Age: 70
Bio & Compensation - Reuters
Christopher C. Chapman Jr., M.D.
Director
Age: 56
Bio & Compensation - Reuters